1. Home
  2. WB vs OGN Comparison

WB vs OGN Comparison

Compare WB & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weibo Corporation

WB

Weibo Corporation

N/A

Current Price

$6.37

Market Cap

1.7B

Sector

Technology

ML Signal

N/A

Logo Organon & Co.

OGN

Organon & Co.

N/A

Current Price

$13.73

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WB
OGN
Founded
2009
1923
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
WB
OGN
Price
$6.37
$13.73
Analyst Decision
Buy
Hold
Analyst Count
17
5
Target Price
$8.24
★ $11.25
AVG Volume (30 Days)
883.9K
★ 2.1M
Earning Date
11-17-2026
11-09-2026
Dividend Yield
★ 9.44%
0.58%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.95
Revenue
N/A
★ $6,216,000,000.00
Revenue This Year
$0.11
N/A
Revenue Next Year
$0.78
$2.51
P/E Ratio
★ $5.66
$14.47
Revenue Growth
★ N/A
N/A
52 Week Low
$6.37
$5.69
52 Week High
$12.77
$13.79

Technical Indicators

Market Signals
Indicator
WB
OGN
Relative Strength Index (RSI) 32.11 53.63
Support Level N/A $13.46
Resistance Level $6.79 $13.77
Average True Range (ATR) 0.10 0.03
MACD 0.02 -0.00
Stochastic Oscillator 25.00 62.50

Price Performance

Historical Comparison
WB
OGN

About WB Weibo Corporation

Weibo Corp is a China-based company that operates a social media platform for people to create, discover and distribute content. The company currently operates and manages its business in two principal business lines globally - advertising and marketing services and value-added services. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The company's main product is the social platform Weibo. It generates a substantial majority of its revenues from online advertising and marketing services.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: